India has joined the list of countries which believe that antiviral favipiravir and immuno-modulator tocilizumab hold promise in treating COVID-19, with the first assessment of redirected drugs/drug combinations to treat the disease by a government task force for the repurposing of drugs (TFORD) showing these two candidates leading the race.
While assessing 19 such potential drugs in terms of their readiness for use and potential against the disease, TFORD, set...






